{"version":"1.0","type":"link","title":"Sprifermin - Newikis","description":"Sprifermin (INN; development code AS-902330) is a recombinant human fibroblast growth factor 18 (rhFGF18) analog, originally developed by Merck, and now being further developed by TrialSpark’s subsidiary, High Line Bio (now Formation Bio), for the treatment of osteoarthritis. FGF18 and sprifermin…","provider_name":"Newikis","provider_url":"https://newikis.com","cache_age":86400}